Skip to main content
HIKMA Pharmaceuticals PLC logo

HIKMA Pharmaceuticals PLC — Investor Relations & Filings

Ticker · HIK ISIN · GB00B0LCW083 LEI · 549300BNS685UXH4JI75 IL Manufacturing
Open in API
Filings indexed 825 across all filing types
Latest filing 2026-05-18 Transaction in Own Shar…
Country GB United Kingdom
Listing IL HIK

About HIKMA Pharmaceuticals PLC

https://www.hikma.com/home/

Hikma Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a broad portfolio of pharmaceutical products. The company's offerings include a wide range of generic, branded, specialty, and in-licensed medicines. It is a significant supplier of generic injectable products to hospitals and also provides oral generics and other specialty medications. With a focus on producing high-quality medicines, Hikma aims to make its products accessible to patients and healthcare providers across its key markets in North America, Europe, and the Middle East & North Africa (MENA) region.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 95% confidence The document is an RNS announcement titled “Transaction in Own Shares” by Hikma Pharmaceuticals PLC, detailing the company’s repurchase of its ordinary shares under a buyback programme, including aggregate and individual trade data. This clearly fits the category for share repurchase transactions. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2026-05-18 English
Change of Registered Office
Regulatory Filings Classification · 88% confidence The document is an RNS announcement titled “Change of Registered Office Address” and simply notifies a change in the company’s registered office. It does not contain financial statements, management changes, capital updates, dividends, or other specialized content. It is a miscellaneous regulatory announcement that does not fit any more specific category, making it a Regulatory Filing (RNS).
2026-05-15 English
Transaction in Own Shares
Transaction in Own Shares Classification · 95% confidence The document is a formal announcement by Hikma Pharmaceuticals PLC detailing the number of its own shares purchased, transaction dates, venues, prices, and references to the share buyback programme. This matches the definition of a Transaction in Own Shares (share repurchase) announcement. Therefore, it should be classified as POS.
2026-05-11 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a notification under Article 19(1) of the EU Market Abuse Regulation regarding acquisitions of ordinary shares by Persons Discharging Managerial Responsibilities (PDMRs) through a dividend reinvestment plan (DRIP). It details insider transactions by company directors or executives. There is no financial report, earnings release, or management discussion present. The content matches the definition of Director's Dealing, which reports personal share transactions by company directors and executives (insider trades). The document length and content confirm it is not a brief announcement or a report publication notice but a full notification of insider transactions.
2026-05-06 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Hikma Pharmaceuticals PLC regarding the purchase of its own shares as part of a share repurchase program. It details the number of shares bought, prices paid, trading venues, and transaction references. The content focuses on transactions in the company's own shares and does not contain financial statements, management discussion, or other report types. The document length is substantial but the content is clearly about share buybacks. Therefore, it fits the category of Transaction in Own Shares (POS).
2026-05-05 English
Group of companies' accounts made up to 2025-12-31
Regulatory Filings
2026-05-04 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.